Publications
Mineralocorticoid receptor antagonism improves corneal integrity in a rat model of limbal stem cell deficiency
Rodrigues-Braz, D., Bonnet, C., Zhu, L., Yesilirmak, N., Gélizé, E., Jonet, L., Jaisser, F., Bourges, J.-L., Behar-Cohen, F., Zhao, M. Biomedicine & Pharmacotherapy. https://doi.org/10.1016/j.biopha.2025.117979
Comparison of in-vitro immunomodulatory capacity between large and small apoptotic bodies from human bone marrow mesenchymal stromal cells
Wang, J., Moosavizadeh, S., Jammes, M., Tabasi, A., Bach, T., Ryan, A. E., Ritter, T. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2025.114480
Excipients in drug delivery systems: A comprehensive review of approved inactive ingredients for human ophthalmic formulations
Arribada, R. G., Rodrigues-Braz, D., Silva-Cunha, A., Behar-Cohen, F. European Journal of Pharmaceutics and Biopharmaceutics. https://doi.org/10.1016/j.ejpb.2025.114637
Healing the cornea: Exploring the therapeutic solutions offered by MSCs and MSC-derived EVs
Jammes, M., Tabasi, A., Bach, T., Ritter, T. (2025). Progress in Retinal and Eye Research, 105, 101325. https://doi.org/10.1016/j.preteyeres.2024.101325
Selective, Temporary Postoperative Inhibition of Lymphangiogenesis by Integrin α5β1 Blockade Improves Allograft Survival in a Murine Model of High-Risk Corneal Transplantation.
Dietrich-Ntoukas T, Bock F, Onderka J, Hos D, Bachmann BO, Zahn G, Cursiefen C. J. Clin. Med. 2024; 13(15):4418. https://doi.org/10.3390/jcm13154418
Spironolactone Eyedrop Favors Restoration of Corneal Integrity after Wound Healing in the Rat
Rodrigues-Braz D, Zhu L, Gélizé E, Clarin J-P, Chatagnon X, Benzine Y, Rampignon P, Thouvenin A, Bourges J-L, Behar-Cohen F, et al. Spironolactone Eyedrop Favors Restoration of Corneal Integrity after Wound Healing in the Rat. Pharmaceuticals. 2023; 16(10):1446. https://doi.org/10.3390/ph16101446
Interested in Restore vision?
Stay informed about our efforts to combat rare eye diseases and bring new hope to those affected by visual impairment by subscribing to our newsletter for updates on our latest treatments and research.